Title:
ＶＥ－カドヘリン発現促進剤及び／又はインテグリンα５発現促進剤
Document Type and Number:
Japanese Patent JP7236390
Kind Code:
B2
Abstract:
The purpose of the present invention is to provide a substance related to the stabilization of capillary blood vessels. This invention is based on the discovery that an extract from a plant selected from the group consisting of Calendula officinalis, Siberian ginseng, and Cistanche salsa increases gene expression of VE-cadherin or integrin α5.
More Like This:
| JP2020002014 | INHIBITORY ACTIVITY AND PURIFICATION METHOD THEREOF |
| WO/2008/088033 | HIV-PROTEASE INHIBITOR AND METHOD FOR PRODUCTION THEREOF |
| JP2018038407 | FAT-BASED FOOD PRODUCTS |
Inventors:
Kentaro Kajiya
Yuko Matsumoto
Yuko Matsumoto
Application Number:
JP2019554296A
Publication Date:
March 09, 2023
Filing Date:
November 15, 2018
Export Citation:
Assignee:
Shiseido Co., Ltd.
International Classes:
A61K36/062; A61P9/14; A61P43/00
Domestic Patent References:
| JP2014520797A | ||||
| JP2011201811A | ||||
| JP2016187324A | ||||
| JP2005272413A |
Foreign References:
| US20160220477 | ||||
| WO2004075621A1 | ||||
| WO2017183581A1 |
Other References:
Cent. Eur. J. Biol., 2011, Vol.6, No.3, pp.330-341
Press Release, シベリア人参がリンパ管に働きかけ「むくみ」を改善することを発見, (株)資生堂, ホームページ, 2016.07.05, [retreived on 2018.12.20], retreived from the internet:,https://www.shiseidogroup.jp/newsimg/1963_x3k98_jp.pdf
Press Release, シベリア人参がリンパ管に働きかけ「むくみ」を改善することを発見, (株)資生堂, ホームページ, 2016.07.05, [retreived on 2018.12.20], retreived from the internet:
Attorney, Agent or Firm:
Aoki Atsushi
Shinji Mihashi
Youichi Watanabe
Nakajima Masaru
Ryotaro Takei
Hidenao Tsuda
Shinji Mihashi
Youichi Watanabe
Nakajima Masaru
Ryotaro Takei
Hidenao Tsuda
Previous Patent: Transdermal therapeutic system containing asenapine
Next Patent: Method for producing activated carbon
Next Patent: Method for producing activated carbon